Category Specific RSS

News

Commonwealth Intelligence Agency engages archTIS for 8 week cybersecurity trial

With data and cyberspace being the contemporary medium for international espionage, Australia is increasing its vigilance with a Commonwealth Intelligence Agency engaging cybersecurity firm archTIS (ASX: AR9) for an 8 week contract.

Over those 8 weeks, archTIS will run a Proof of Concept to implement policy-based access to movement of big data between agencies in real time which will provide customised access to big data.

“The real-time sharing of big data sets between different organisations is a complex problem at the best of times,” said archTIS CEO, Daniel Lai.

“And this challenge is further compounded when there are high information security and compliance obligations associated with the management and release of different data and data sets.”

“This is a significant global problem for Government agencies and I am delighted that archTIS is part of the solution.”

The 8 week contract, which is expected to commence in mid-September, is valued at a fixed price of $85,000, acting as a scoping exercise for archTIS to identify the data sharing needs and shortfalls within the Agency. Should the Proof of Concept be successful, further functionalities and services may be introduced in the future.

The contract follows up another similar data sharing contract which archTIS won in May 2020 to assist Curtin University’s space tracking data sharing challenges. Earlier in the week, archTIS also reported a contract awarded by global consultancy firm KPMG valued up to $400,000 for cybersecurity services.

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

3 days ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

4 days ago

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…

1 week ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…

3 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

4 months ago

Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…

4 months ago